Eyeworld Supplements

EW JUN 2022 - Supported by Alcon

This is a supplement to EyeWorld Magazine.

Issue link: https://supplements.eyeworld.org/i/1465711

Contents of this Issue

Navigation

Page 2 of 7

SUPPLEMENT TO EYEWORLD DAILY NEWS, APRIL 23, 2022 | 3 Supported by Alcon He said that while the design makes sense, it will take time and thousands of cases to better understand its efficacy. The precision-edge design may help to reduce posterior capsule opacification by limiting cell migration. 7 With monofocal lenses being what surgeons implant most of the time, Dr. Vroman said, "The Clareon ® IOL is going to be a beautiful workhorse lens. "The transition from the AcrySof ® SN60s and SA60s to this material is going to be seamless with some advantages that will be noticeable to both the surgeon and the patient," he said. *Defined as modified Miyata grade 0, <25 mv/mm 2 over 3 years (n=138) and over 9 years (n=20), respectively Editors' note: Dr. Vroman is a cornea, cataract, and refractive surgeon and a founding partner of Carolina Cataract & Laser Center in Ladson, South Carolina. He can be contacted at DrVroman@ carolinacataract.com. continued from page 2 Refer to page 8 for Important Product Information about the Alcon products described in this supplement. The AutonoMe® Delivery System: 'A complete revolution' T he innovative features of the Clareon ® IOL platform (Alcon) don't stop at the IOL. Currently, the Clareon ® IOL is exclusively delivered through a new IOL delivery system, the AutonoMe ® Delivery System, which one surgeon described as "a com- plete revolution." The AutonoMe ® Delivery System is preloaded with the Clareon ® IOL and features automated, controlled deliv- ery via a CO2-powered delivery mechanism. 8 Brian Shafer, MD, has been using the Clareon ® IOL as his "go-to monofocal lens" since late 2021, performing more than 100 cataract surgeries thus far with the new platform. "The AutonoMe ® Delivery System is a complete rev- olution when it comes to delivery of intraocular lenses. There are other preloaded injectors … but this is the first CO2-powered injector that delivers the lens with a respon- sive speed control lever," Dr. Shafer said. Dr. Shafer described what he thinks are several advan- tages to this delivery system. 1. Single-handed injection: Most IOLs are injected with a two-handed technique. The AutonoMe ® Delivery System allows for single-handed injection, leaving the other hand free to stabilize the eye. 8,9,10 2. Consistent, controlled delivery: By incorporating a response-speed control lever, the AutonoMe ® Delivery System provides consistent yet titratable speed of intra- ocular lens insertion. 8,9,10 Dr. Shafer said certain IOLs, particularly hydrophilic IOLs, can vary with their speed of delivery. "With controlled delivery, you can be confident that your IOL will safely enter the eye," Dr. Shafer said. Brian Shafer, MD 3. Proprietary depth guard: This feature allows the in- jector to dock into incisions as small as 2.2 mm without significant stretching. 11,12 Maintaining the wound size is important to get an appropriate seal at the end of the case, in addition to accurately predicting surgically induced astigmatism. Studies have compared wound size before and after delivery with the AutonoMe ® Delivery System and other injectors. Dr. Shafer said the AutonoMe ® Delivery System is designed to protect incisions as small as 2.2 mm with a proprietary depth guard. 8,12 "It allows you to deliver this lens through a very small wound while maintaining the wound architecture, which is phenomenal," he said. 4. Preloaded: The most common time that the optic of an IOL sustains damage is during the loading process. Dr. Shafer said preloaded IOLs are designed to maintain optical clarity and stability. 5. Little to no learning curve: Dr. Shafer said this delivery system has a low learning curve. "It's so straightforward. The key is to use more viscoelastic than you think you need in the injector and to deliver the lens within 1 min- ute of pressing the button," he said. Editors' note: Dr. Shafer is a cataract, refractive, cornea, and glaucoma surgeon at Chester County Eye Care in Malvern, Pennsylvania. He can be contacted at brian.m.shafer@ gmail.com.

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld Supplements - EW JUN 2022 - Supported by Alcon